Stressgen Biotechnologies Corporation
Stressgen is a public biopharmaceutical company focused on the
development and commercialization of innovative stress protein-
based immunotherapeutics. The Company is developing a broad
range of products for the treatment of viral infections and
related cancers, such as anal dysplasia, genital warts, cervical
dysplasia and cervical cancer.
In addition to targeting HPV-related diseases, the Company also
has a program to evaluate stress protein fusions in hepatitis B
and has initiated research studies to evaluate its heat shock
protein technology in the treatment of several other indications
such as HIV and herpes.
Stressgen is an internationally recognized supplier of research
products used by scientists worldwide for the study of cellular
stress, apoptosis, oxidative stress, and neurobiology.
Company Details
Year Established:
1990
Total Sales ($CDN):
$5,000,000 - $10,000,000
Number of Employees:
94
Company Information
Jennifer Matterson
Title:
Communications Co-Ordinator
Telephone:
(250) 744-2811
Fax:
(250) 744-3331
Email:
Click Here
Donna Slade
Title:
Director of Investor Relations
Area of Responsibility:
Management Executive
Telephone:
(250) 744-2811
Fax:
(250) 744-2877
Email:
Click Here
Daniel Korpolinski
Title:
Chief Executive Officer
Area of Responsibility:
Management Executive
Telephone:
(250) 744-2811
Fax:
(250) 744-3331
Email:
Click Here
Donald Tartre
Title:
Chief Financial Officer
Area of Responsibility:
Finance/Accounting
Telephone:
(858) 202-4920
Fax:
(858) 450-6849
Products
Biopharmaceutical Products
Laboratory Reagents
Agrin Antibodies - 4
Cell Lysates - 2
Estrogen/Progesterone Receptors - 2
Oxidative Stress Antibodies - 10
Secondary Antibodies - 14
Signal Transduction Antibodies - 17
Signal Transduction Proteins - 19
Stress Protein Antibodies - 56
Stress Proteins & Molecular Chaperones - 23
Substrates - 5
Svt Repicles - 9
Thyroid Hormone Receptor Antibodies - 6
Tissue Extracts - 4
Vescular Trafficking Antibodies - 17
Vt Supernatrants - 8
Pcr Primer Pairs-8
Heat Shock Protein Elisa Kits -3
Research Kits - 6
Services
Vaccine Development